Sharing Life Sciences Innovations

Join our 20.000 subscribers and receive the newsletter for free!

Upcoming events

FlandersBio - Roche Diagnostics partner day

The Classic Domain, Ast 26, 1653 Beersel
Thu 30 Mar 2017
12:00

This partner day reflects the catalyzing role of FlandersBio and Roche Diagnostics to promote knowledge transfer amongst all players in the personalized healthcare field and to better understand t…

Read more

Business Developers Program for Life Sciences

Holiday Inn, Leiden, The Netherlands
Tue 04 Apr 2017 - Wed 05 Apr 2017
04 Apr 08:30 - 05 Apr 17:30

On the 4th and 5th of April the BDP Course will take place at the Holiday Inn in Leiden. This BDP Course specifically aims at junior to mid-level BD professionals who are driven to expand their kn…

Read more

International Francqui Chair: 'Fighting neurodegenerative disorders with gene therapy'

Auditorium 1.008, building S2, Campus Sterre, Krijgslaan 281, 9000 Ghent
Wed 19 Apr 2017
16:00

You are invited to the lectures of the Francqui Chair 2016-2017.

Read more

Investing in European biotech faced with many challenges

Investing in European biotech faced with many challenges

Investing in biotech companies is a capital-intensive and risky business, and it’s no secret that more money and less risk-averse investors are available in the US than in Europe. To keep innovati…

Read more

Kiadis Pediatric Investigation Plan concerning blood cancer approved by EMA

Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders, today announces that the Pedia…

Read more

Non-invasive colorectal cancer screening test

VIB and DNAlytics are proud to announce their partnership to develop a data-driven, high-performance and non-invasive Colorectal Cancer screening test, the ColonoKit.

Read more

Glucose starvation as a weapon in breast cancer

The Massimiliano Mazzone group (VIB-KU Leuven) has recently demonstrated that PP2A/B55α promotes the growth of colorectal cancer, by dephosphorylating PHD2 and modifying its enzymatic properties.

Read more

Grail: A billion-dollar gamble?

Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company will build an atlas of DNA found in the blood, co…

Read more

Partnering for a better mental health

Partnering for a better mental health

To address the challenges of drug development, solid strategic partnerships are needed. On the Janssen partner day, the company showcased an ongoing partnership with the University of Antwerp in m…

Read more

A guinea pig: your perfect partner to produce monoclonal antibodies

A guinea pig: your perfect partner to produce monoclonal antibodies

SynAbs is a young UCL spin-off company, founded in September 2015 with the support of Walloon life science incubator WBC, UCL’s tech transfer office LTTO and the French investment group Biotech In…

Read more

Your body modeled in a computer?

Your body modeled in a computer?

The Virtual Physiological Human (VPH) is a fantastic, noble concept first discussed in Europe in the late nineties. The initiative sought to develop a detailed computer model of a human to “enable…

Read more

Personalized Arthritis Medicine Saves Lots of Money

Personalized Arthritis Medicine Saves Lots of Money

Detecting arthritis early on is one of the key challenges facing rheumatology. However, some patients present with undifferentiated arthritis, meaning that it is not possible to establish a diagno…

Read more

Interspecies chimeras: One embryo, two species

Interspecies chimeras: One embryo, two species

The creation of an interspecies embryo in the lab sends tremors through the scientific world and beyond. This pig embryo containing human cells presents many exciting possibilities, such as creati…

Read more

V-Bio feature: Mosquito Wars

V-Bio feature: Mosquito Wars

Mosquitoes are carriers of a range of crippling diseases, posing an enormous global health burden. Because current methods based on insecticides are inadequate, new tools are urgently needed. Wide…

Read more

Join our 20.000 subscribers and receive the newsletter for free!

Upcoming events

FlandersBio - Roche Diagnostics partner day

The Classic Domain, Ast 26, 1653 Beersel
Thu 30 Mar 2017
12:00

This partner day reflects the catalyzing role of FlandersBio and Roche Diagnostics to promote knowledge transfer amongst all players in the personalized healthcare field and to better understand t…

Read more

Business Developers Program for Life Sciences

Holiday Inn, Leiden, The Netherlands
Tue 04 Apr 2017 - Wed 05 Apr 2017
04 Apr 08:30 - 05 Apr 17:30

On the 4th and 5th of April the BDP Course will take place at the Holiday Inn in Leiden. This BDP Course specifically aims at junior to mid-level BD professionals who are driven to expand their kn…

Read more

International Francqui Chair: 'Fighting neurodegenerative disorders with gene therapy'

Auditorium 1.008, building S2, Campus Sterre, Krijgslaan 281, 9000 Ghent
Wed 19 Apr 2017
16:00

You are invited to the lectures of the Francqui Chair 2016-2017.

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

UGent Bridge 2 Health Lifetech.brussels Biowin VIB FlandersBio Turnstone V-Bio Ventures KU Leuven Janssen Itera Life Science NLO GSK

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.